Stock Catalyst AI
VIP Login VIP €10

Why is $PLSE moving today? · Filing archive

$PLSE SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $PLSE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $PLSE filing catalyst

Why did $PLSE trigger an AI stock catalyst alert?

$PLSE triggered a Stock Catalyst AI alert on 2026-11-06 15:14:33 UTC for a Filing filing (AI Score: +6.5/10). Headline: Pulse Biosciences Reports Positive Six-Month Thyroid Nodule Trial Results. Key points: - 86% of patients achieved >50% thyroid nodule volume reduction at six months - Median nodule volume reduction reached 72% across 43 patients - Zero serious adverse events reported across three U.S. clinical trial sites

How did $PLSE stock react after the SEC filing?

After the Filing for $PLSE, observed market reaction: T0 price $52.82; 4h move -1.02%; peak move +0.98%. Past moves do not guarantee future results.

Where can I get real-time $PLSE SEC filing alerts?

Stock Catalyst AI pushes real-time Filing alerts for $PLSE via Telegram and the VIP Web Terminal from €10/month.

$PLSE

$PLSE – Pulse Biosciences Reports Positive Six-Month Thyroid Nodule Trial Results

· Filing · All $PLSE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)
  • 86% of patients achieved >50% thyroid nodule volume reduction at six months
  • Median nodule volume reduction reached 72% across 43 patients
  • Zero serious adverse events reported across three U.S. clinical trial sites
Observed market reaction after signal
4h -1.02% · Peak +0.98%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing →
$PLSE

$PLSE – Pulse Biosciences Reports Positive PRECISE-BTN Six-Month Interim Data

PULSE BIOSCIENCES, INC.
· SEC 8-K · All $PLSE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)
  • 86% of patients achieved primary endpoint of ≥50% thyroid nodule volume reduction at six months.
  • Median nodule volume reduction was 72% with zero serious adverse events reported.
  • ThyPRO-39 Quality of Life score improved by 78%, supporting commercial and regulatory progress.
Observed market reaction after signal
4h -0.67% · Peak +7.16%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing →
$PLSE

$PLSE – Pulse Biosciences Reports Q3 Results, Completes IDE Study Enrollment

PULSE BIOSCIENCES, INC.
· SEC 8-K · All $PLSE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+1.5 / 10)
  • Fully enrolled NANOPULSE-AF US IDE pivotal study for cardiac catheter system
  • Cash, cash equivalents, and marketable securities totaled $189M
  • GAAP R&D expenses increased to ~$16.8M for the quarter vs ~$11.3M prior year
Unlock Live VIP Terminal & Telegram – €10/mo Original filing →